Xin-Fu Zhou Selected Research

brain-derived neurotrophic factor precursor

1/2021	Brain-derived neurotrophic factor precursor in the immune system is a novel target for treating multiple sclerosis.
1/2016	Peripheral Brain Derived Neurotrophic Factor Precursor Regulates Pain as an Inflammatory Mediator.
2/2010	Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release.
11/2006	Axonal transport of BDNF precursor in primary sensory neurons.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin-Fu Zhou Research Topics

Disease

35	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 10/2006
14	Neuroinflammatory Diseases 01/2022 - 10/2009
9	Pain (Aches) 01/2022 - 05/2002
8	Ischemic Stroke 08/2022 - 04/2015
8	Ischemia 08/2022 - 04/2017
8	Amyloid Plaque 12/2021 - 03/2009
7	Neoplasms (Cancer) 11/2017 - 02/2013
6	Parkinson Disease (Parkinson's Disease) 01/2022 - 12/2015
6	Inflammation (Inflammations) 07/2021 - 12/2005
5	Cognitive Dysfunction 01/2022 - 03/2009
5	Hypoxia (Hypoxemia) 08/2021 - 04/2015
5	Huntington Disease (Huntington's Disease) 01/2020 - 01/2009
5	Stroke (Strokes) 10/2019 - 08/2016
5	Spinal Cord Injuries (Spinal Cord Injury) 01/2018 - 01/2005
4	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 11/2017
4	Brain Ischemia (Cerebral Ischemia) 10/2019 - 04/2017
4	Hyperalgesia 01/2014 - 06/2003
3	Gliosis 04/2018 - 10/2009
3	Bone Fractures (Bone Fracture) 03/2018 - 07/2006
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2018 - 07/2014
3	Glioma (Gliomas) 07/2015 - 08/2013
3	Neuralgia (Stump Neuralgia) 06/2006 - 05/2002
2	Cerebral Infarction 08/2022 - 10/2019
2	Hypertrophy 04/2022 - 01/2014
2	Body Weight (Weight, Body) 01/2022 - 01/2014
2	Atrophy 01/2022 - 11/2014
2	Multiple Sclerosis 01/2021 - 03/2012
2	Mood Disorders (Mood Disorder) 01/2021 - 11/2016
2	Brain Injuries (Brain Injury) 01/2019 - 01/2019
2	Salter-Harris Fractures 11/2018 - 07/2006
2	Neuroblastoma 10/2018 - 01/2018
2	Alcoholism (Alcohol Abuse) 01/2018 - 01/2017
2	Pancreatitis 01/2018 - 08/2016
2	Hypersensitivity (Allergy) 01/2016 - 09/2011
2	Genomic Instability 01/2016 - 02/2009
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2022
1	Chronic Disease (Chronic Diseases) 04/2022
1	Diabetic Cardiomyopathies 04/2022
1	Insulin Resistance 01/2022
1	Rheumatoid Arthritis 01/2022
1	Depressive Disorder (Melancholia) 01/2022
1	Obesity 01/2022
1	Frontotemporal Dementia (Semantic Dementia) 12/2021

Drug/Important Bio-Agent (IBA)

25	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 01/2005
21	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2006
18	Amyloid beta-PeptidesIBA 12/2021 - 10/2006
12	Amyloid (Amyloid Fibrils)IBA 01/2018 - 02/2009
9	sortilinIBA 10/2019 - 06/2013
8	Nerve Growth Factors (Neurotrophins)IBA 01/2022 - 06/2003
7	EdaravoneIBA 08/2022 - 04/2015
6	AntibodiesIBA 01/2021 - 03/2002
6	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 07/2019 - 02/2013
6	Nerve Growth Factor (NGF)IBA 01/2018 - 03/2002
5	LipopolysaccharidesIBA 01/2022 - 10/2019
4	CytokinesIBA 01/2022 - 04/2018
4	Free Radical ScavengersIBA 12/2021 - 04/2015
4	EnzymesIBA 01/2021 - 10/2015
4	brain-derived neurotrophic factor precursorIBA 01/2021 - 11/2006
3	CurcuminIBA 01/2022 - 02/2009
3	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 01/2022 - 01/2016
3	Neuroprotective AgentsIBA 04/2021 - 01/2017
3	scutellarinIBA 01/2021 - 04/2018
3	Therapeutic UsesIBA 01/2021 - 03/2008
3	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2018 - 08/2016
3	Pharmaceutical PreparationsIBA 01/2018 - 04/2017
3	nafamostatIBA 01/2018 - 08/2016
2	Caspase 3 (Caspase-3)IBA 08/2022 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2022 - 07/2019
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
2	Streptozocin (Streptozotocin)FDA Link 01/2022 - 08/2021
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 07/2021 - 12/2015
2	Recombinant ProteinsIBA 03/2021 - 01/2020
2	Biological ProductsIBA 01/2021 - 03/2012
2	Panax notoginsenoside saponin Rb1IBA 10/2019 - 01/2018
2	ginsenoside Rb1IBA 10/2019 - 04/2017
2	Nimodipine (Modus)FDA LinkGeneric 10/2019 - 04/2017
2	RotenoneIBA 01/2019 - 12/2015
2	MetalsIBA 10/2018 - 01/2018
2	CopperIBA 10/2018 - 01/2018
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2016 - 09/2011
2	Morphine (MS Contin)FDA LinkGeneric 01/2014 - 01/2010
2	Peptides (Polypeptides)IBA 06/2013 - 10/2012
2	Neutralizing AntibodiesIBA 11/2010 - 06/2003
2	PolyphenolsIBA 02/2009 - 01/2009
2	Grape Seed ExtractIBA 02/2009 - 01/2009
1	Vesicle-Associated Membrane Protein 2 (VAMP2)IBA 08/2022
1	Free RadicalsIBA 04/2022
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 04/2022
1	CollagenIBA 04/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	Hormones (Hormone)IBA 01/2022
1	hyperosideIBA 12/2021

Therapy/Procedure

6	Therapeutics 11/2021 - 01/2010
3	Transplantation 11/2021 - 07/2014
3	Axotomy 06/2006 - 05/2002
2	Oral Administration 12/2021 - 04/2015
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2021 - 01/2018
2	Immunotherapy 01/2010 - 03/2009